Indies Pharma Jamaica Limited (JMSE: INDIES)
Jamaica
· Delayed Price · Currency is JMD 3.100
+0.200 (6.90%)
At close: Nov 18, 2024
Indies Pharma Jamaica Cash Flow Statement
Financials in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 | 2018 - 2016 |
| Net Income | 215.57 | 213.06 | 220.79 | 167.87 | 207.35 | 130.96 | Upgrade
|
| Depreciation & Amortization | 60.47 | 60.16 | 56.84 | 53.73 | 48.9 | 12.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.12 | -3.07 | -1.88 | -2.4 | - | - | Upgrade
|
| Other Operating Activities | 101.65 | 77.57 | 59.07 | 62.95 | 10.7 | -14.13 | Upgrade
|
| Change in Accounts Receivable | -17.18 | -103.5 | -5.32 | 60.12 | 71.38 | -26.57 | Upgrade
|
| Change in Inventory | -100.15 | 5.13 | 47.09 | -76.08 | 10.42 | -1.74 | Upgrade
|
| Change in Accounts Payable | -31.63 | 29.26 | 3.03 | -31.49 | 11.56 | 20.86 | Upgrade
|
| Change in Income Taxes | -34.17 | - | - | -0.14 | -0.12 | -0.06 | Upgrade
|
| Change in Other Net Operating Assets | -5.44 | 0.88 | -64.39 | 131.91 | -444.3 | 45.76 | Upgrade
|
| Operating Cash Flow | 188 | 279.47 | 315.22 | 366.48 | -84.11 | 167.35 | Upgrade
|
| Operating Cash Flow Growth | -47.64% | -11.34% | -13.99% | - | - | -15.71% | Upgrade
|
| Capital Expenditures | -3.4 | -14.02 | -26.37 | -40.72 | -25.41 | -60.27 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.58 | 3.53 | 1.88 | 2.98 | 0.7 | 8.45 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -0 | - | Upgrade
|
| Sale (Purchase) of Intangibles | 5.61 | -62.44 | -61.68 | -202.93 | -114.7 | - | Upgrade
|
| Investment in Securities | -5.68 | 63.14 | 67.31 | 0.75 | -147.5 | - | Upgrade
|
| Other Investing Activities | 90.88 | 1.46 | 0.95 | 4.84 | -114.31 | 0.32 | Upgrade
|
| Investing Cash Flow | 88.99 | -8.33 | -17.92 | -235.09 | -401.22 | -51.5 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 799.58 | - | Upgrade
|
| Long-Term Debt Issued | - | 0.06 | 3.43 | 0.6 | 77.05 | 4.34 | Upgrade
|
| Total Debt Issued | -79.88 | 0.06 | 3.43 | 0.6 | 876.63 | 4.34 | Upgrade
|
| Long-Term Debt Repaid | - | -46.35 | -48.16 | -46.63 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -160.55 | -46.29 | -44.73 | -46.03 | 876.63 | 4.34 | Upgrade
|
| Common Dividends Paid | -146.98 | -150.98 | -150.58 | -146.58 | -186.56 | -106.6 | Upgrade
|
| Other Financing Activities | -55.72 | -56.35 | -56.2 | -61.37 | -9.19 | -0.2 | Upgrade
|
| Financing Cash Flow | -363.25 | -253.62 | -251.5 | -253.99 | 680.89 | -102.46 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.45 | 0.45 | 0.1 | - | - | - | Upgrade
|
| Net Cash Flow | -64 | 17.98 | 45.89 | -122.59 | 195.56 | 13.39 | Upgrade
|
| Free Cash Flow | 184.61 | 265.45 | 288.85 | 325.76 | -109.52 | 107.08 | Upgrade
|
| Free Cash Flow Growth | -44.54% | -8.10% | -11.33% | - | - | -45.61% | Upgrade
|
| Free Cash Flow Margin | 16.25% | 25.15% | 30.82% | 38.47% | -14.30% | 14.68% | Upgrade
|
| Free Cash Flow Per Share | 0.14 | 0.20 | 0.22 | 0.24 | -0.08 | 0.08 | Upgrade
|
| Cash Interest Paid | 49.07 | 56.35 | 56.2 | 61.37 | 9.19 | 0.2 | Upgrade
|
| Cash Income Tax Paid | - | -7.87 | 0.32 | - | - | 7.97 | Upgrade
|
| Levered Free Cash Flow | 7.48 | 73.53 | 111.44 | -74.56 | 120.05 | -4.23 | Upgrade
|
| Unlevered Free Cash Flow | 44.8 | 115.27 | 149.24 | -31.46 | 126.16 | 1.8 | Upgrade
|
| Change in Net Working Capital | 199.66 | 37.33 | -4.38 | -22.57 | -81.62 | 35.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.